Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ovation ScienceOVATF Days Sales Outstanding is 37.33 as of Mar. 2026, which is 59% below its 10-year median of 90.64. The stock has 4 warning signs investors should review. Among 947 Drug Manufacturers companies, Ovation Science ranks better than 91.97% on this metric.
Ovation Science (OTCPK:OVATF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Ovation Science Days Sales Outstanding Related Terms
Ovation Science Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Ovation Science's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Ovation Science's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ovation Science Days Sales Outstanding vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ovation Science's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Ovation Science's Days Sales Outstanding falls into.
Ovation Science Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ovation Science (OVATF) has a Days Sales Outstanding of 37.33 as of Mar. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Ovation Science and its competitors. This is 59% below median its historical median of 90.64. Over the past decade, Ovation Science's Days Sales Outstanding has ranged from 22.87 to 174.57. According to the industry distribution chart, Ovation Science ranks #76 out of 947 companies in the Drug Manufacturers industry, placing it in the top 8%.
Is Ovation Science's Days Sales Outstanding too high?
Ovation Science's current Days Sales Outstanding of 37.33 is 59% below median its 10-year median of 90.64. Over the past 10 years, this metric has ranged from a low of 22.87 to a high of 174.57. The Drug Manufacturers industry median Days Sales Outstanding is 71.98. Ovation Science's value of 37.33 is 48.1% below this industry median. Based on the distribution chart, Ovation Science ranks #76 out of 947 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Ovation Science's Days Sales Outstanding compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Ovation Science ranks #76 out of 947 companies for Days Sales Outstanding. This places Ovation Science in the top 8% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 71.98. Ovation Science's value of 37.33 is 48.1% below this benchmark. Historically, Ovation Science's own Days Sales Outstanding has ranged from 22.87 to 174.57 over the past decade. While the company's 10-year median is 90.64 vs. the industry median of 71.98, Ovation Science has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Drug Manufacturers company?
The median Days Sales Outstanding among Drug Manufacturers companies is 71.98, based on 947 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ovation Science's current Days Sales Outstanding of 37.33 is 48.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Ovation Science and its competitors. For the Drug Manufacturers industry, the median Days Sales Outstanding is 71.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ovation Science's current Days Sales Outstanding is 37.33, which is 59% below median its own 10-year median of 90.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ovation Science stock overvalued right now?
Based on GuruFocus' analysis, Ovation Science (OVATF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.03, compared to a current price of $0.01 — trading 75% below its estimated fair value. The current Days Sales Outstanding is 37.33, which is 59% below median its 10-year median of 90.64 and 48.1% below the Drug Manufacturers industry median of 71.98. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Ovation Science (OVATF), the current Days Sales Outstanding is 37.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ovation Science Inc. is a Canada-based company mainly engaged in the business of providing topical and transdermal cannabis products under the Ovation brand label, utilizing patented Invisicare delivery technology. The Company operates in one reportable operating segment, the sub-licensing and sales of cannabis products that utilize Invisicare, a patented polymer-based technology for topical and transdermal skin care products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OVATF has been successfully added to your 
